Vaxcyte, Inc. - Common Stock — Cash Flow (NASDAQ:PCVX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -46.63 M-121.39 M-170.6 M-296.79 M-452.63 M-655.58 M -769.93 M Cash from investing activities -1.1 M-212.31 M74.58 M-773.31 M-2.01 B437.35 M 80.63 M Cash from financing activities 374.87 M17.8 M861.55 M639.81 M2.45 B2.01 M 602.84 M Free cash flow -46.63 M-121.39 M-170.6 M-296.79 M-452.63 M-669.29 M -780.32 M

News

Top 3 Health Care Stocks You'll Regret Missing In May - Vaxcyte (NASDAQ:PCVX), Universal Health Services

How S&P Drug Titan Pfizer Plans To Outdo Its Own $6 Billion Franchise

Vaxcyte Stock: Manufacturing-Backed Vaccine Platform Redefining PCV Market (NASDAQ:PCVX)

Jefferies reiterates Vaxcyte stock Buy rating on regulatory clarity

BTIG raises Vaxcyte price target to $89 on vaccine breadth edge

Leerink raises Vaxcyte stock price target on vaccine pipeline expansion

Vaxcyte, Inc. (PCVX) Q4 2025 Earnings Call Transcript

Ovintiv to Report Q4 Earnings: What's in Store for the Stock?

Vaxcyte closes $632.5 million public offering of common stock

Vaxcyte prices $550 million public offering of common stock

Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

Vaxcyte launches $500 million public offering of common stock